|
STIP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.03869999998641E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.32439999978429E-07 |
| Normal-vs-Stage2 |
5.441600E-04 |
| Normal-vs-Stage3 |
3.48319999954327E-07 |
| Normal-vs-Stage4 |
9.426100E-02 |
| Stage1-vs-Stage2 |
8.755200E-01 |
| Stage1-vs-Stage3 |
2.418800E-01 |
| Stage1-vs-Stage4 |
1.029000E-01 |
| Stage2-vs-Stage3 |
3.664800E-01 |
| Stage2-vs-Stage4 |
2.147800E-01 |
| Stage3-vs-Stage4 |
3.010000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.32589999985089E-07 |
| Normal-vs-AfricanAmerican |
4.46610000000014E-05 |
| Normal-vs-Asian |
5.850600E-01 |
| Caucasian-vs-AfricanAmerican |
4.319000E-01 |
| Caucasian-vs-Asian |
2.646600E-01 |
| AfricanAmerican-vs-Asian |
2.272200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.78400000117441E-08 |
| Normal-vs-Female |
5.189100E-04 |
| Male-vs-Female |
4.549800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.522120E-03 |
| Normal-vs-Age(41-60Yrs) |
3.23049999995106E-06 |
| Normal-vs-Age(61-80Yrs) |
1.42380000001108E-06 |
| Normal-vs-Age(81-100Yrs) |
1.180230E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.132000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.121800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.446400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.869600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.025400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.388800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.701550E-01 |
| Normal-vs-Grade 2 |
1.16380000081406E-08 |
| Normal-vs-Grade 3 |
2.71550000041643E-07 |
| Normal-vs-Grade 4 |
2.680600E-01 |
| Grade 1-vs-Grade 2 |
2.038000E-01 |
| Grade 1-vs-Grade 3 |
3.118000E-01 |
| Grade 1-vs-Grade 4 |
7.858800E-01 |
| Grade 2-vs-Grade 3 |
9.144800E-01 |
| Grade 2-vs-Grade 4 |
3.158100E-02 |
| Grade 3-vs-Grade 4 |
4.048000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.72379999455686E-08 |
| Normal-vs-ccB subtype |
2.377900E-04 |
| ccA subtype-vs-ccB subtype |
2.804000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.53620000001398E-07 |
| Normal-vs-N1 |
5.514600E-01 |
| N0-vs-N1 |
2.110000E-01 |
|
|
